- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Guardian Pharmacy Services, Inc. (GRDN)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/18/2025: GRDN (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $34
1 Year Target Price $34
| 2 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 12.43% | Avg. Invested days 30 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.97B USD | Price to earnings Ratio 45.81 | 1Y Target Price 34 |
Price to earnings Ratio 45.81 | 1Y Target Price 34 | ||
Volume (30-day avg) 3 | Beta - | 52 Weeks Range 17.78 - 37.43 | Updated Date 12/19/2025 |
52 Weeks Range 17.78 - 37.43 | Updated Date 12/19/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.68 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.9% | Operating Margin (TTM) 4.48% |
Management Effectiveness
Return on Assets (TTM) 10.55% | Return on Equity (TTM) 24% |
Valuation
Trailing PE 45.81 | Forward PE 30.21 | Enterprise Value 1970034748 | Price to Sales(TTM) 1.42 |
Enterprise Value 1970034748 | Price to Sales(TTM) 1.42 | ||
Enterprise Value to Revenue 1.42 | Enterprise Value to EBITDA 24.26 | Shares Outstanding 36253744 | Shares Floating 23131028 |
Shares Outstanding 36253744 | Shares Floating 23131028 | ||
Percent Insiders 37.91 | Percent Institutions 57.79 |
Upturn AI SWOT
Guardian Pharmacy Services, Inc.

Company Overview
History and Background
Guardian Pharmacy Services, Inc. was founded in 2000. It has grown to become a leading provider of pharmacy services, focusing on long-term care facilities, assisted living, and other healthcare settings. Significant milestones include its expansion across multiple states and its strategic partnerships with various healthcare organizations. The company's evolution has been driven by a commitment to personalized patient care and efficient medication management solutions.
Core Business Areas
- Long-Term Care Pharmacy: Guardian Pharmacy Services provides comprehensive pharmacy solutions tailored for long-term care facilities. This includes dispensing medications, medication management systems, clinical pharmacy services, and resident-focused care plans.
- Specialty Pharmacy Services: The company offers specialized pharmacy services for patients with complex medical conditions, including chronic diseases and rare disorders, ensuring access to necessary medications and ongoing support.
- Infusion Pharmacy: Guardian Pharmacy provides intravenous (IV) therapy services, including the preparation and delivery of complex IV medications for home or facility-based administration, managed by specialized clinical teams.
- Medical Supplies and Durable Medical Equipment (DME): In addition to pharmaceuticals, Guardian Pharmacy often offers a range of medical supplies and durable medical equipment to support patient care in various settings.
Leadership and Structure
Guardian Pharmacy Services, Inc. is privately held. Key leadership positions typically include a CEO, COO, CFO, and heads of various operational and clinical departments. The organizational structure is often decentralized to allow for regional management and localized client support, while maintaining centralized strategic direction and support functions.
Top Products and Market Share
Key Offerings
- Medication Management Systems: Guardian Pharmacy provides advanced medication management systems, including automated dispensing cabinets, electronic charting, and prescription refill management. Competitors include Omnicell, BD Pyxis, and McKesson's solutions. Specific market share data for this product line is not publicly available, but it is a critical component of their service offering for institutional clients.
- Clinical Pharmacy Consultations: This service involves pharmacists providing in-depth reviews of resident medication regimens to optimize therapy, identify drug interactions, and improve patient outcomes. This is a core differentiator and directly competes with in-house pharmacy departments or services offered by other long-term care pharmacy providers. Market share is embedded within the overall long-term care pharmacy market.
- Specialty Drug Dispensing and Support: Guardian Pharmacy dispenses and provides patient support for high-cost, complex specialty medications used for conditions like cancer, autoimmune diseases, and rare genetic disorders. Competitors include companies like Accredo (Evernorth), CVS Specialty Pharmacy, and Optum Rx Specialty. Their market share in this niche is not independently reported.
Market Dynamics
Industry Overview
The long-term care pharmacy market is a significant segment of the broader pharmaceutical services industry. It is characterized by an aging population, increasing prevalence of chronic diseases, and a growing demand for efficient and integrated medication management solutions. The industry is highly regulated and driven by reimbursement policies, operational efficiency, and the ability to provide high-quality patient care.
Positioning
Guardian Pharmacy Services is positioned as a comprehensive pharmacy solutions provider for institutional clients, particularly in the long-term care sector. Their competitive advantages include a focus on personalized care, advanced technology for medication management, and strong relationships with healthcare providers. They aim to differentiate themselves through clinical expertise and operational efficiency.
Total Addressable Market (TAM)
The TAM for long-term care pharmacy services in the US is estimated to be in the tens of billions of dollars annually. Guardian Pharmacy Services, as a significant player, aims to capture a substantial portion of this market by offering a full suite of services and expanding its geographic reach. Their positioning is strong within the segment they serve, focusing on integrated care models.
Upturn SWOT Analysis
Strengths
- Established reputation and strong client relationships in the long-term care sector.
- Advanced technology for medication management and dispensing.
- Clinical expertise and focus on patient outcomes.
- Scalable operational model to support growth.
Weaknesses
- As a privately held company, financial transparency is limited.
- Dependence on reimbursement rates and regulatory changes.
- Intense competition from larger pharmacy benefit managers (PBMs) and national pharmacy chains.
Opportunities
- Expansion into new geographic markets.
- Growth in home infusion and specialty pharmacy services.
- Strategic partnerships with healthcare systems and accountable care organizations (ACOs).
- Leveraging data analytics for improved patient care and operational efficiency.
Threats
- Increasing regulatory scrutiny and compliance burdens.
- Price pressures from payers and government programs.
- Cybersecurity risks and data breaches.
- Consolidation within the healthcare and pharmacy industries.
Competitors and Market Share
Key Competitors
- Omnicare, Inc. (CVG)
- PharMerica Corporation (independent)
- CVS Health Corporation (CVS)
- Walgreens Boots Alliance (WBA)
Competitive Landscape
Guardian Pharmacy Services competes in a fragmented market with larger, publicly traded entities and numerous regional players. Their competitive advantage lies in their specialized focus on long-term care and commitment to personalized service, while larger competitors often leverage scale and broader service portfolios. The ability to offer integrated solutions and maintain strong clinical relationships is crucial.
Growth Trajectory and Initiatives
Historical Growth: Guardian Pharmacy Services has experienced significant historical growth, driven by strategic acquisitions, organic expansion into new territories, and an increasing demand for their specialized pharmacy services in the long-term care and post-acute care sectors.
Future Projections: Future growth is expected to be driven by continued market penetration in existing service areas, expansion into new demographic regions, and the development of new service offerings to meet evolving healthcare needs. Specific analyst projections are not available for private companies.
Recent Initiatives: Recent initiatives likely focus on technological integration, enhancing clinical service offerings, expanding service lines into related healthcare sectors, and potentially strategic partnerships or smaller acquisitions to broaden their service footprint.
Summary
Guardian Pharmacy Services, Inc. is a significant player in the long-term care pharmacy market, distinguished by its specialized services and focus on patient outcomes. While its private status limits financial transparency, its historical growth and strategic positioning suggest a robust operational model. The company faces intense competition and regulatory pressures, but opportunities exist in market expansion and service diversification. Continued investment in technology and clinical expertise will be crucial for sustained success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company website (for general information on services and history)
- Industry reports and market analysis (for TAM and competitive landscape)
- General knowledge of the US pharmacy and long-term care sectors
Disclaimers:
Financial data for Guardian Pharmacy Services, Inc. is not publicly available as it is a privately held company. Market share percentages for individual companies are estimations based on industry reports and may not be precise. The AI-based rating is an automated assessment and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Guardian Pharmacy Services, Inc.
Exchange NYSE | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2024-09-26 | CEO, President & Director Mr. Fred P. Burke | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 3400 | Website https://guardianpharmacy.com |
Full time employees 3400 | Website https://guardianpharmacy.com | ||
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

